Topical Cyclosporin A in the Management of Postkeratoplasty Glaucoma

Abstract

Topical cyclosporin A 0.5% may be substituted for topical corticosteroids to aid in the management of postkeratoplasty patients with glaucoma. However, the resultant decrease in IOP may be associated with an increased risk for immune rejections.